Nurix Therapeutics, Inc.
Industry: Life Sciences ・ $NRIX on Nasdaq
Insider Sale
+$75,868
-6.38%
Shares
Shares Volume: 3,477 Shares
Average Share Price: $21.82
INSIDER
van Houte Hans
Chief Financial Officer (Officer)
reported on Aug 1 2024
traded on Aug 1 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
NEW SHARES OWNERSHIP AMOUNT | 51,002 |
PURCHASES/SALES 1Y | 0 / 9 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $90,578.4 |
INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
PURCHASES/SALES 1Y | 0 / 21 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $65,062.32 |
COMPANY PREVIOUS TRADES |